The impact of compression garments on the quality of life in patients with chronic venous disease

Demczyszak, Iwona; Sutkowska, Edyta; Jasiak, Magdalena; Fortuna, Małgorzata; Mazurek, Justyna

doi:10.1515/physio-2016-0011

Cited by 2 publications

(2 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In patients with VLUs, the QoL impairment increses gradually, which is reflected in worsening physical (RP, PF, BP, GH) and mental (SR, RE) scores [ 24 ]. The largest CVD-related QoL deterioration is seen in the pain domain [ 21 , 32 ].…”

Section: Discussionmentioning

confidence: 99%

The effect of compression therapy on quality of life in patients with chronic venous disease: a comparative 6-month study

Berszakiewicz

Kasperczyk²,

Sieroń

et al. 2021

pdia

View full text Add to dashboard Cite

Introduction: Chronic venous diseases (CVD), because of its chronic and progressive nature, impairs patients' quality of life (Qol). Aim: To compare the QoL in patients with primary superficial venous insufficiency at different stages before and after compression therapy (CT). Material and methods: We compared the change in the QoL parameters from baseline to the end of a 6-month compression therapy. 180 subjects were enrolled. They were subdivided into 6 equal subgroups according to CEAP classes. The QoL was assessed using questionnaires, the general SF-36v2 and the disease-specific CIVIQ-20. At the beginning and after the completion of the study intervention, the severity of CVD was assessed in each patient using CEAP and VCSS. The pain intensity was assessed using the numerical rating scale. Results: The CT reduced the severity of CVD, which translated into the increased size of C2 an d C5 subgroups, and reduced size of C3 and C6 subgroups. Another marker of reduced severity of CVD after CT was a significant reduction in VCSS scores in C1, and C3-C6 subgroups. A 6-month CT was associated with a significant QoL improvement in all CEAP class-based subgroups, across all individual and composite domains of SF-36v2, as well as dimensions and GIS of CIVIQ-20. Similarly, there was a significant pain reduction reported in all CEAP class-based subgroups. Conclusion: Compression therapy using ready-made compression hosiery significantly affects the quality of life in patients with chronic venous disease at all its stages, CEAP classes C1-C6.

show abstract

Section: Discussionmentioning

confidence: 99%

The effect of compression therapy on quality of life in patients with chronic venous disease: a comparative 6-month study

Berszakiewicz

Kasperczyk²,

Sieroń

et al. 2021

pdia

View full text Add to dashboard Cite

show abstract

“…Compression therapy is a primary treatment modality for both chronic edema 29 and chronic venous insufficiency, 30 a common condition 31 and a known cause of chronic edema. 32 Compression therapy has been found to increase the rate of healing for venous ulcers, 33 reduce the rate of venous ulcer recurrence, 34 reduce limb volume, 13 improve skin condition, 29 improve quality of life for patients with chronic venous disease, 35 and may prevent post-thrombotic syndrome. 36 Furthermore, it is used to manage conditions that mimic cellulitis, such as lipodermatosclerosis.…”

Section: Discussionmentioning

confidence: 99%

Compression Therapy Is Cost-Saving in the Prevention of Lower Limb Recurrent Cellulitis in Patients with Chronic Edema

Webb

Bissett

Neeman

et al. 2023

Lymphatic Research and Biology

View full text Add to dashboard Cite

Background: Cellulitis is a common and often recurrent infection that causes substantial financial burden and morbidity. Compression therapy reduces the risk of recurrent cellulitis episodes for adults with chronic edema; however, little is known about the cost-effectiveness of the intervention. Methods and Results: A cost analysis was undertaken during a randomized controlled trial (RCT) involving 84 participants with lower limb chronic edema and a history of recurrent cellulitis. The intervention group received compression therapy and education, while the control group received education only. A clinical audit and survey were used to measure health service and patient resource use for (1) the most recent episode of cellulitis, and (2) compression therapy over 18 months. Australian reference costs were used to calculate cellulitis and compression therapy costs, and the mean expenditure in both the RCT groups. Of the 84 RCT participants, 43 were surveyed and audited on the cost of cellulitis, and 40 on the cost of compression therapy. The mean cost of a hospitalized and nonhospitalized episode of cellulitis was $9071 and $506 from a health service perspective, and $4496 and $1320 from a patient perspective. The mean cost of compression therapy per participant over 18 months was $1905 and $421 from health service and patient perspectives, respectively. During the RCT, the mean annual cost per participant was $4972 in the experimental group and $26,382 in the control group, giving a cost-saving of $21,483 (95% confidence interval, 3136–48,176) per participant. Conclusion: For patients with lower limb chronic edema and recurrent cellulitis, compression therapy is both efficacious and cost-saving. Trial Registration: ACTRN12617000412336.

show abstract

The impact of compression garments on the quality of life in patients with chronic venous disease

Cited by 2 publications

References 13 publications

The effect of compression therapy on quality of life in patients with chronic venous disease: a comparative 6-month study

The effect of compression therapy on quality of life in patients with chronic venous disease: a comparative 6-month study

Compression Therapy Is Cost-Saving in the Prevention of Lower Limb Recurrent Cellulitis in Patients with Chronic Edema

Contact Info

Product

Resources

About